Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
544 hedge funds and large institutions have $7.57B invested in Exact Sciences in 2024 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 211 increasing their positions, 179 reducing their positions, and 138 closing their positions.
20% more call options, than puts
Call options by funds: $91.9M | Put options by funds: $76.5M
18% more repeat investments, than reductions
Existing positions increased: 211 | Existing positions reduced: 179
6.44% more ownership
Funds ownership: 90.59% → 97.03% (+6.4%)
13% less funds holding
Funds holding: 627 → 544 (-83)
33% less capital invested
Capital invested by funds: $11.3B → $7.57B (-$3.77B)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
54% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 138
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$676M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$226M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$213M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$191M |
| 5 |
State Street
Boston,
Massachusetts
|
+$171M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$443M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$161M |
| 3 |
Millennium Management
New York
|
-$125M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$97.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$87.6M |
EXAS Hedge Fund Activity: Q2 2024 in Review
544 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2024, worth a combined $7.57B — down 33% from $11.3B a quarter earlier.
Sellers outnumbered buyers: 138 funds closed out of EXAS and 63 opened new positions — a net loss of 75 holders — while 179 trimmed existing stakes and 211 added.
The largest buyer was Fidelity Investments, adding an estimated $676M. The largest seller was JP Morgan Chase, cutting an estimated $443M.
- 544 institutional investors held Exact Sciences (EXAS) as of Q2 2024, down from 627 in Q1 2024.
- Funds reported $7.57B of Exact Sciences stock for Q2 2024, down 33% quarter-over-quarter.
- 63 funds opened new Exact Sciences positions in Q2 2024 and 138 closed out, a net change of -75 holders.
- The largest Exact Sciences buyer in Q2 2024 was Fidelity Investments, an estimated $676M added.
- The largest Exact Sciences seller in Q2 2024 was JP Morgan Chase, an estimated $443M sold.
Based on aggregated 13F filings for Q2 2024.